Source: FirstWord Pharma

Proteros: Proteros Expands Oncology Collaboration and License Agreement with AstraZeneca

-- Under the expanded collaboration, Proteros will receive additional research funding, milestone payments plus royalties -- MUNICH--(BUSINESS WIRE)-- Proteros biostructures GmbH ("Proteros"...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Torsten Neuefeind's photo - Co-Founder & CEO of Proteros

Co-Founder & CEO

Torsten Neuefeind

CEO Approval Rating

85/100

Read more